Feature | Oncology Information Management Systems (OIMS) | October 04, 2018 | By Pratik Kirve

Improving Cancer Care with OIMS

New research advancements and emphasis on quality care will help transform the oncology information management system industry

Pratik Kirve

Pratik Kirve

Research advancements related to usage of radiation oncology in breast cancer and emphasis on quality care along with support from governments are expected to bring significant transformation in the oncology information management system (OIMS) industry.

Oncology information systems have always improved the quality of care and outcomes of oncology treatments. The leading organizations of the oncology professionals have recently urged governments to improve cancer care. The American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) have released a joint statement urging governments to enhance cancer services along with reducing deaths due to cancer. The findings by the World Health Organization (WHO) stated that 1.9 million people lose their lives from cancer every year in Europe. The statement outlined that oncologists have been working hard to make sure patients receive the best care and are expanding their knowledge regarding how to treat it. They believe that curing some of the cancers is possible with early intervention.

“However, in many countries access to even the most inexpensive essential cancer medicines and priority medical devices is lacking,” said Alexandru Eniu, chair of the ESMO Global Policy Committee. “We urgently need governments to work with us and ensure that we have enough oncology professionals, and the necessary resources, to apply our knowledge and save lives.”

Reports of the United Nations (UN) and WHO highlighted that each country needs to improve their actions and investments to reduce death from cancer. The implementation of cost-effective ways to improve care and provide expertise in cancer management would enable a reduction in deaths.

 

Alternative Payment Models

In another attempt to improve care for patients, radiation oncologists emphasized the use of alternative payment models (APM). They met with Congress at Capitol Hill to discuss policies regarding access to high-quality care for patients with cancer and how APMs would be beneficial. They also emphasized providing support to research and development activities with continuous funding and protecting medical access to radioactive materials. As part of the American Society of Radiation Oncology (ASTRO) Advocacy Day, the team of radiation oncologists met Congress members to gain their support and participation in the transition to value-based healthcare across the nation.

ASTRO has collaborated with the Center for Medicare and Medicaid Innovation (CMS) for development and launch of a Radiation Oncology Alternative Payment Model (RO-APM). It helps in speeding up the shift from volume to value along with including utilization of APMs as a means for Medicare reimbursement. RO-APM involves giving incentives for adherence to clinical guidelines for cancers including breast, colorectal, lung, prostate, and head and neck. Moreover, it ensures fair and predictable payment for radiation oncologists, offering incentives to cancer treatments given with high quality of care and the best outcomes from patients.

Brian Kavanagh, M.D., MPH, FASTRO, chair of the ASTRO Board of Directors, said in a statement, “Congress must prevent any additional payment cuts to radiation therapy centers to avoid jeopardizing access to critical, life-saving services and compromising our progress toward value-based care.” The value-based care would improve outcomes and oncology information systems would play a crucial part. The oncology information system market would grow significantly, registering a compound annual growth rate (CAGR) of 7.5 percent from 2016 to 2022, according to the research firm Allied Market Research.1

 

Hypofractionated Whole Breast Irradiation

Along with the development of the RO-APM model, ASTRO has recommended hypofractionated whole breast irradiation (HF-WBI) for patients suffering from breast cancer without restriction on age, stage of the tumor and previous chemotherapy treatments. The new guideline encourages a bigger role of patients in the selection of HF-WBI. According to the previous guidelines, HF-WBI was restricted to women over 50 with T1-2 N0 disease. However, new guidelines make HF-WBI available for all patients regardless of their hormone receptor (HR) status, tumor grade and HER2 status.

“The evidence base has matured since our last guideline, so this new guideline is more expansive in the types of patient for whom it endorses the use of hypofractionated whole breast radiation,” Benjamin Smith, M.D., co-chair of the guideline task force and an associate professor of radiation oncology at The University of Texas MD Anderson Cancer Center in Houston, told OncLive, an online oncology resource.2

The results from various trials have shown that the outcomes from HF-WBI are similar to conventional fractionation (CF) WBI. The usage of WBI for a broader patient population has been approved, and it will be used for patients of breast cancer regardless of age, tumor stage and previous treatments. There will be decisions taken from a collaboration between oncologists and patients. Oncologists also believe that the best decisions are made from the context of shared decisions.

There have been significant advancements in radiation oncology for the treatment of patients with breast cancer. Naamit K. Gerber, M.D., assistant professor, Department of Radiation Oncology, NYU Langone’s Perlmutter Cancer Center, explored those advancements in her recent interview with OncLive.3 The launch of deep inspiration breath hold (DIBH) technique has been vital for restraining the heart dose. DIBH shifts the heart away from the left breast or chest wall. Patients are asked to take deep breaths that inflate the lungs and create distance between the left breast and the heart. Radiologists then target the left breast and restrain the cardiac dose. Gerber outlined that patients who have early-stage breast cancer and patients who want to treat their lymph nodes will benefit from this technique. She also outlined that this technique has been implemented throughout the nation. Though there are many techniques available, a simple technique such as DIBH is tremendously useful and offers quality patient care.

 

Pratik Kirve is a writer and blogger. He holds a bachelor’s degree in electronics and telecommunication engineering and currently working as a content writer at Allied Analytics LLP. He has avid interest in writing news articles across different verticals.

 

References

1. Oncology Information System Market Report, Allied Market Research. https://www.alliedmarketresearch.com/oncology-information-system-market. Accessed Sept 4, 2018.

2. www.onclive.com/publications/oncology-live/2018/vol-19-no-13/astro-guidelines-support-accelerated-whole-breast-radiation-for-most-patients. Accessed Sept 4, 2018.

3. www.onclive.com/onclive-tv/dr-gerber-on-advances-in-radiation-oncology-in-breast-cancer. Accessed Sept 4, 2018.

Related Content

Important milestone demonstrates the unrivalled experience, technological innovation and global market leadership of IBA and its clinical partners
News | Proton Therapy | September 25, 2020
September 25, 2020 — IBA (Ion Beam Applications SA) announced that more than 100,000 patients have now been treated w
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...